On Tuesday, March 6, Wilson Sonsini Goodrich & Rosati announced that Joshua Soven has joined the firm’s antitrust practice as a partner in the Washington, D.C. office.
Soven previously served in high-level positions at the US Department of Justice (DOJ) and the Federal Trade Commission (FTC). Most recently, he was a litigation partner in the Washington, D.C., office of Gibson, Dunn & Crutcher.
Soven’s practice focuses on government antitrust investigations, antitrust litigation, and counseling on antitrust and competition matters. He represents clients before the DOJ Antitrust Division, the FTC, and in federal courts. He also has extensive experience handling antitrust reviews before competition authorities in jurisdictions throughout the world.
In addition to representing leading public and private companies in the technology and life sciences industries, Soven’s clients include energy, financial services, healthcare, and retail companies. He has served as lead global antitrust counsel in strategic transactions for leading companies, including AECOM, Avnet, Francisco Partners, Hewlett-Packard Enterprise, LinkedIn, Matson, Norbord, Retalix, Southern Power, St. Jude Medical, and Tenet Healthcare. He represented LinkedIn in its US$26 billion sale to Microsoft and St. Jude Medical in its US$25 billion sale to Abbott Laboratories.
Full Content: PR Newswire
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Confusion Reigns In AI Policy In US and Europe
May 13, 2025 by
CPI
EU Clears ADNOC’s $16.3 Billion Acquisition of Covestro
May 13, 2025 by
CPI
Spanish Antitrust Chief Says BBVA-Sabadell Merger Won’t Stifle Competition
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece